Identifying patients at risk for thromboembolism. Use of 125I-labeled fibrinogen in patients with acute myocardial infarction
- 13 December 1976
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 236 (24) , 2755-2757
- https://doi.org/10.1001/jama.236.24.2755
Abstract
Fibrinogen labeled with 125I was used to detect deep vein thrombosis (DVT) in 35 patients during their course and convalescence from acute myocardial infarction. Clinical status was assessed and scored with the use of a modified coronary prognostic index. According to the prognostic scores, patients were allocated to 1 of 2 groups. Of 27 patients in good clinical condition, DVT developed in only 1 patient, whereas thromboembolic complications occurred in 7 of 8 patients who were severely ill, a highly significant difference. Prophylactic anticoagulation was advisable in patients at risk.This publication has 0 references indexed in Scilit: